NVIDIA, Intel, Marvell, and Other AI Stocks Plunged Today
The AI rally cooled as major chip makers like NVIDIA, Intel, and Marvell pulled back. This article breaks down why th...
Tax Lots Change With Portfolio Rebalance
During a rebalance, which tax lots remain, get sold, or new lots form can shift. This intro explains the typical changes and implications.
20,499 articles
Should Oklo Stock While It’s Below $55? A Clear-Cut Investor Guide
Oklo is building small modular reactors with a bold future. But should oklo stock while it trades under $55 be part o...
Account Minimums Being Lowered: SpaceX IPO Win or Trap?
Retail investors may finally gain access to SpaceX’s IPO as account minimums being lowered promise a wider door. This...
Reasons IBM's COBOL Fears: Why They're Overblown Today
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
Materials: Buy, Sell, Hold? MP Materials Stock Outlook
MP Materials sits at the intersection of U.S. manufacturing ambitions and global rare-earth supply. This guide breaks...
Bitcoin Jumps Three-Month High: What It Means Right Now
Bitcoin surged to a three-month high, topping the $82,000 mark amid fresh geopolitical chatter and improving market s...
Johnson Johnson Just Paid a $1B Bet on Undruggable Target
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Tilray Growing Internationally: Market Watch and Risks
Tilray is expanding beyond its home market, but the stock market isn’t fully pricing in that growth. This article bre...
PFXF’s 6.7% Yield: Safe—Unless the Signal Flips Soon
The VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
Viking Therapeutics Stock No-Brainer: Is It Worth Buying Below $35?
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
Allogene (ALLO) 2026 Earnings Outlook for Investors
This guide breaks down what to watch in allogene (allo) 2026 earnings. Learn how pipeline progress, cash runway, and ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status